Molecular typing is predicated on molecular genetic tests and is not still routinely accessible. Molecular subtypes and immunohistochemical surrogate markers from the tumors (HR, HER2, triple detrimental) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 might be https://davej318cls5.wikibriefing.com/user